The challenges of access to innovative medicines with limited evidence in the European Union

Overview of attention for article published in Frontiers in Pharmacology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 17 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 9,303 followers.

RT @annabonet: Los desafíos del acceso a medicamentos innovadores con evidencia limitada en la Unión Europea - PMC #FarmaciaICS ⁦@salutcat…

25 Oct 2023

Reply Repost Favourite

Los desafíos del acceso a medicamentos innovadores con evidencia limitada en la Unión Europea - PMC #FarmaciaICS ⁦@salutcat⁩ ⁦@icscat⁩ https://t.co/sON2XjhUDH

25 Oct 2023

Reply Repost Favourite

The challenges of access to innovative medicines with limited evidence in the European Union https://t.co/A9uqsE2xII #ScientiaVH

26 Sep 2023

Reply Repost Favourite

The challenges of access to innovative medicines with limited evidence in the European Union https://t.co/YeuarZ0pZ0 #hvhebron #farm [Text complet] @FrontPharmacol

22 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.